Emtricitabine Active Not Recruiting Phase 4 Trials for Severe Immunosuppression / Human Immunodeficiency Virus (HIV) Infections Treatment

Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01380080REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
NCT02529059SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms
NCT03693508A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression